NASDAQ · Medical - Instruments & Supplies

Akoya Biosciences, Inc. (AKYA) Stock

$1.29 -5.15% NASDAQ: AKYA Healthcare

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions.

Valuation

MetricValue
Price$1.29
Market Cap$64.44M
P/E Ratio-1.15
P/B Ratio8.39
P/S Ratio0.79
EPS (TTM)$-1.12
52-Week High$3.42
52-Week Low$0.93
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-180.44%
ROA-44.29%
ROCE-48.90%
Gross Margin58.62%
Operating Margin-57.22%
Net Margin-67.79%
Debt/Equity11.08
Current Ratio2.61

Annual Financials (USD)

Metric20202021202220232024
Revenue$42.0M$55.0M$75.0M$97.0M$82.0M
Operating Profit$-11.0M$-37.0M$-66.0M$-58.0M$-47.0M
Net Profit$-17.0M$-43.0M$-71.0M$-63.0M$-55.0M
EPS$-0.45$-1.19$-1.87$-1.43$-1.12
Op Margin-27.1%-67.8%-88.4%-59.7%-57.2%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$78.0M$191.0M$176.0M$180.0M$125.0M
Total Liabilities$59.0M$70.0M$117.0M$127.0M$117.0M
Cash$17.0M$113.0M$74.0M$83.0M$12.0M
Borrowings$35.0M$33.0M$76.0M$86.0M$84.0M

Latest News

KBRA Releases Research – Net Lease REITs: Ramping Development for Growth Business Wire · Aug 10, 2026 KBRA Assigns Preliminary Ratings to BMO 2026-C15 Business Wire · Aug 10, 2026 Market expert sees likely 10% stock pullback this year Reuters Videos · Aug 10, 2026 VOC Energy: Q2 Earnings Snapshot Associated Press · Aug 10, 2026 Global stocks mixed while oil prices jump on Hormuz AFP · Aug 10, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-7.0M$-36.0M$-53.0M$-51.0M$-44.0M
Investing Cash Flow$3.0M$-10.0M$-21.0M$0$-27.0M
Financing Cash Flow$-4.0M$0$-2.0M$-2.0M$-2.0M
Net Cash Flow$5.0M$96.0M$-39.0M$9.0M$-71.0M
Free Cash Flow$-10.0M$-41.0M$-61.0M$-55.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-3.68
FCF Yield-72.25%
Quick Ratio1.78
Interest Coverage-4.48
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHLAchilles Therapeutics plc $1.48 +0.68% -0.85 $60.83M 0.00%
HTBXHeat Biologics, Inc. $2.38 +0.42% -1.87 $61.07M 0.00%
LFWD $7.00 -1.41% -0.39 $11.28M 0.00%
NEUENeueHealth, Inc. $6.75 +0.00% -1.22 $60.94M 0.00%
OMICSingular Genomics Systems, Inc. $20.01 +0.00% -0.51 $50.77M 0.00%

About Akoya Biosciences, Inc.

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samples—such as fresh frozen or FFPE sections and tissue microarrays—through an efficient, automated, and high-throughput process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.

Akoya Biosciences, Inc. is headquartered in US.

Akoya Biosciences, Inc. (AKYA) stock trades at $1.29 with a market capitalization of $64.44M. The stock is valued at a price-to-earnings (P/E) ratio of -1.15, price-to-book of 8.39, price-to-sales of 0.79. Over the past 52 weeks the stock has ranged between $0.93 and $3.42, and currently trades 62.3% below its 52-week high.

On profitability, Akoya Biosciences, Inc. generates a return on equity (ROE) of -180.44%, return on capital employed of -48.90%, an operating margin of -57.22%, a net profit margin of -67.79%.

Official website: www.akoyabio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides